Intrathecal Pump Drug Delivery
Idioma: inglés
Editorial: Springer, Berlin|Springer International Publishing|Springer, 2022
- Tapa dura
- Nuevo

Librería: moluna, Greven, Alemaniamoluna
Vendedor de AbeBooks desde 9 de julio de 2020
Condición: Nuevo
EUR 132,75
Cantidad disponible: Más de 20 disponibles
Añadir al carritoDescripción del artículo del vendedor
Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book is a comprehensive guide to Targeted Drug Delivery (TDD), also known as Intrathecal Drug Delivery (IDD), and offers an overview to this unique form of treatment. The medication is delivered by intrathecal pumps and is less common than some other t.
N° de ref. del artículo 492756330
- Título
- Intrathecal Pump Drug Delivery
- Editorial
- Springer, Berlin|Springer International Publishing|Springer
- Año de publicación
- 2022
- Estado
- New
- Encuadernación
- Gebunden
- Idioma
- inglés
- ISBN 10
- 3030862437
- ISBN 13
- 9783030862435
- Catálogos de vendedores
- Mathematik/Naturwissenschaften/Technik/Medizin
This book is the first source to describe both the optimal surgical implantation and patient management aspect of this therapy, and thus will be a valuable single reference guide for interventional radiologists, anesthesiologists, physiatrists, oncologists, neurologists, spine surgeons, palliative care physicians, and primary care physicians.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Douglas P. Beall, MD, attended medical school at Georgetown University School of Medicine in Washington, DC, and completed his residency at The Johns Hopkins Hospital in Baltimore, Maryland. Following residency, he was Chief of Interventional Services at Sheppard Air Force Base in Wichita Falls, Texas. He then completed a fellowship in Musculoskeletal Radiology at Mayo Clinic in Rochester, Minnesota, where he was trained in interventional spine techniques before returning to the US Air Force as Division Chief of Musculoskeletal Radiology. Following his service as a Major in the US Air Force Dr. Beall was chief of Musculoskeletal Radiology and Fellowship Director at the Univiersity of Oklahoma prior to entering private practice as the Chief of Services.
In addition to his expertise in musculoskeletal imaging and interventional spine care, Dr. Beall is actively involved in teaching and research. He is board-certified in Diagnostic Radiology, has an added fellowship in Musculoskeletal Radiology, is a Diplomate of the American Academy of Pain Management and is a Fellow of the Society of Interventional Radiology and Interventional Pain Practice and board certified by the World Institute of Pain. He is currently in private practice focused on interventional pain management and orthopedic imaging.
Dr. Beall has published more than 250 articles in peer-reviewed journals, authored 6 textbooks and 75 textbook chapters, given more than 1000 invited lectures and scientific presentations and has participated in 55 clinical research trials. He is currently the Chief of Services for Comprehensive Specialty Care in Oklahoma City as well as the Division Head of Interventional Spine Care and Director of Pain Management Fellowship Programs at the Center for Comprehensive Specialty Care.Peter L Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon) is Professor of Radiology, Orthopedics and Palliative Care at the University of British Columbia and former Section Head Musculoskeletal Imaging at the Vancouver General Hospital in Vancouver, Canada. A medical graduate of McGill University in Montreal, Canada. Completed a Fellowship in musculoskeletal radiology at the University of California San Francisco.
Previous Editor in Chief of the Canadian Association of Radiologists Journal (2009-2019) and currently Associate Editor of the British Journal of Radiology, Advisor to the Editor Medical Journal of Australia. International Liaison for the Asian Pacific Association of Medical Journal Editors. Author of 460 published papers, 180 abstracts, 120 scientific exhibits, 5 books and 25 book chapters. Member of the International Skeletal Society, Fellow of the Society of Interventional Radiology and Honorary Fellow of the Faculty of Radiology of the Royal College of Surgeons in Ireland.Principle research interest includes musculoskeletal tumor imaging and Interventional imaging guided musculoskeletal procedures - particularly with regards to pain control in metastatic bone disease.
Michael J. DePalma, MD is President and Medical Director of Virginia iSpine Physicians, PC where he practices Interventional Spine and Musculoskeletal Care. Dr. DePalma completed his residency in Physical Medicine and Rehabilitation at The Ohio State University Medical Center in 2003 followed by his fellowship training in Interventional Spine Care at the Pennsylvania Spine Center of the Hospital of the University of Pennsylvania in 2004.
Dr. DePalma has authored or co-authored over eighty-five articles and abstracts in peer reviewed journals and twenty-one textbook chapters. He has also edited a forty-nine chapter textbook, iSpine: Evidence Based Interventional Spine Care, and co-edited a second textbook, Regenerative Medicine: The Intersection of Research and Experience. He serves or has served on multiple professional committees and boards for the North American Spine Society, The Spine Intervention Society, and the American Academy of Physical Medicine and Rehabilitation. Dr. DePalma is a reviewer for leading peer reviewed journals within his specialty as well as online patient education website. He serves as Director of Virginia iSpine Physician’s Interventional Spine Care Fellowship program and is also Chairman and Director of Research with Virginia Spine Research Institute. Dr. DePalma has been named by his peer physicians as a “Top Doc” in Richmond Magazine in 2008, 2011, and 2012, in Best Doctors in America 2015-2016, and in Virginia magazine in 2017. This esteemed recognition places Dr. DePalma within the top 10% of recognized physicians in this area. He is also the recipient of the 2018 Our Health Best Bedside Manner Award as well as the 2019 Medarva Patient Choice Award. Dr. DePalma is an active spine and musculoskeletal researcher with over 18 years of clinical research experience. As a Principal Investigator he has successfully conducted various phases of FDA regulated clinical trialsfor conditions such as degenerative disc disease (DDD), spinal stenosis, disc herniation, facet joint arthrosis, hip joint arthritis sacroiliac joint dysfunction, osteoporotic fractures and, more recently, knee osteoarthritis. His research has corroborated prevalence data on chronic low back pain and has also clarified predictor variables for the source of chronic low back pain and the etiology of chronic low back pain induced by motor vehicle collision. He was the lead investigator at VCU in the largest prospective study of an innovative non-surgical technique to stabilize painful pelvic fractures in osteoporotic patients.As an international speaker as an expert in his field, Dr. DePalma’s research has been recognized twice by the Spine Intervention Society as the “Best Clinical Paper” and “Best Basic Science Paper”.
Dr DePalma’s Clinical Research Team includes two Sub-Investigators including his fellows, a Certified Clinical Research Coordinator, a Clinical ResearchAssistant, and several Clinical Research Medical Assistants. Together, the research team at Virginia iSpine Physicians, PC has over 45 Years of combined clinical research experience.
Timothy T Davis, MD attended the University of Missouri-Kansas City School of Medicine 6 year Program, graduating with a combined BA/MD at 24 years of age. After earning his medical degree, Dr. Davis completed his surgical internship at Ochsner Medical Foundation in New Orleans, Louisiana then his residency in Physical Medicine and Rehabilitation at the West Los Angeles Veterans Administration and UCLA Medical Center. He then completed a post graduate Spine Fellowship at The Spine Institute in Santa Monica, CA. Dr. Davis has published extensively in peer reviewed journals, has written numerous book chapters, and has presented nationally and internationally on spine and joint disorders and treatments. He has been the principal investigator on more than 20 clinical trials,many focusing on biologics for spine and joint disorders.Dr Davis has been in Private Practice focused on Interventional Pain Management for his entire medical career and is the founder of Source Healthcare, Source Surgery Center, Source Practice Solutions IP Holdings, and Alpha Diagnostics.
Dr Davis is on medical staff at Saint Johns Health Center and Cedars Sinai Medical Center. He is a member of the North American Spine Society, American Academy of Physical Medicine and Rehabilitation, American Academy of Pain Medicine, North American Neuromodulation Society and American Society of Pain and Neuroscience.
Kasra Amirdelfan is one of the founding partners at IPM Medical Group, Inc., in Walnut Creek, California. He received his medical degree from Texas A&M University, College of Medicine. He completed his residency at John Peter Smith Hospital in Fort Worth, Texas, an affiliated facility with Southwestern School of Medicine. Dr.Amirdelfan completed his fellowship in Interventional Pain Management at Pacific Pain Treatment Centers with Dr. Elliot Krames, in collaboration with California Pacific Medical Centers in San Francisco. He has served as the Department Chair of Pain Medicine at John Muir Medical Center and Doctors Hospitals in his area. He performs extensive research and lectures various cutting edge methods in pain management at the national and international levels. He is regarded as one of the foremost global key opinion leaders in the field of Interventional Pain Management and Neuromodulation. He also continues to be actively involved in conducting research for the development of new technologies to help improve pain management worldwide. He has authored over 40 scientific peer-reviewed publications in his specialty. He in the Vice President of Clinical Affairs and an executive board member of the American Society of Pain & Neuroscience (ASPN). He is also the Vice President of PacificSpine & Pain Society (PSPS). Dr. Amirdelfan has a special interest in Spinal diseases, spinal cord stimulation and stem cell technologies.
Corey W. Hunter, M.D. is an interventional pain management physician practicing in New York City, holding board certifications in Physical Medicine & Rehabilitation and Pain Medicine.
Dr. Hunter earned his medical degree from Drexel University College of Medicine. Thereafter, he completed a residency in PM&R at New York University followed by a Pain Medicine fellowship at the Weill Cornell Medical Center. Dr. Hunter went on to found the Ainsworth Institute of Pain Management in New York City where he serves as the Executive Director. In addition, he holds an appointment as Assistant Clinical Professor in PM&R at the Icahn School of Medicine at Mount Sinai Medical Center.
Prior to attending medical school, Dr. Hunter worked as a research assistant at the Miami Project to Cure Paralysis investigatingembryonic stem cells to treat paralysis, Parkinson’s disease and chronic pain. He continued his research in medical school studying stromal stem cells (now known as mesenchymal) to treat paralysis – his work was amongst the earliest research on this particular cell line, which is now the mainstay of regenerative medicine.
Dr. Hunter continues to be active in research, serving as the principle investigator on a number of clinical trials on emerging neuromodulation technologies and regenerative medicine. He has a keen interest in teaching and is well-published with his work appearing in a number peer-reviewed journals and textbooks on a wide variety of topics that includes DRG Stimulation, pelvic pain, regenerative medicine, CRPS, amputee pain, advanced spinal cord stimulation techniques, and targeted drug delivery.
“Acerca de” puede pertenecer a otra edición de este título.
moluna
Greven, Alemania
Vendedor de AbeBooks desde 9 de julio de 2020
Tarifas de envío de Alemania a Estados Unidos de America
| Artículo | De 26 a 60 días hábiles | De 26 a 60 días hábiles |
|---|---|---|
| Primer artículo | EUR 48,99 | EUR 48,99 |
Métodos de pago
- Cheque
- Giro bancario
- PayPal
Descripción de la tienda
Online Handel nur mit Neubüchern
Información empresarial del vendedor
Moluna GmbH
Engberdingdamm 27
Greven, Alemania 48268
Condiciones de venta
Aviso legal
Reconocimiento legal del oferente:
Moluna GmbH
Representadas por el gerente Helge Blischke
Engberdingdamm 27
48268 Greven
Alemania
Teléfono: 02571/5698933
Fax: 02571/5698930
E-Mail: abe@moluna.de
Identificación tributaria del impuesto a las ganancias: DE296281834
inscripto en el Registro Público de Comercio del Tribunal de Primera Instancia Steinfurt
Número HRB de Registro en el Registro Público de Comercio 10553
Somos miembros de la iniciativa « FairCommerce » desde 24.07.2015.
Para más información, consulte: www.haendlerbund.de/faircommerce.
Derecho al desistimiento
Si es un consumidor, puede rescindir el contrato de acuerdo con lo siguiente. Por consumidor se entiende cualquier persona física que actúe con fines ajenos a su actividad comercial, empresarial, oficio o profesión.
Información sobre el derecho de desistimiento
Derecho legal de desistimiento
Tiene derecho a rescindir este contrato en un plazo de 14 días sin dar ningún motivo.
El periodo de desistimiento vencerá a los 14 días desde que usted, o un tercero que no sea el transportista e indicado por usted, adquiera la posesión física del último bien o del último lote o pieza.
Para ejercer el derecho de desistimiento, complete de forma electrónica y envíe una declaración clara en nuestro sitio web, desde "Mis compras" en "Mi cuenta". Le enviaremos sin demora un acuse de recibo de dicho desistimiento a través de un soporte duradero (por ejemplo, por correo electrónico).
Para cumplir con el plazo de desistimiento, basta con que envíe su comunicación relativa al ejercicio del derecho de desistimiento antes de que venza el periodo de desistimiento.
Efectos del desistimiento
Si rescinde este contrato, le reembolsaremos todos los pagos que hayamos recibido de usted, incluidos los gastos de envío (excepto los gastos adicionales que surjan si elige un tipo de envío que no sea el tipo de envío estándar más económico que ofrecemos).
Podemos hacer una deducción del reembolso por la pérdida de valor de cualquier bien suministrado, si la pérdida es el resultado de una manipulación innecesaria por su parte.
Efectuaremos el reembolso sin demoras indebidas y, a más tardar, 14 días después de que se nos informe de su decisión de rescindir este contrato.
Efectuaremos el reembolso utilizando el mismo medio de pago que utilizó para la transacción inicial, a menos que haya acordado expresamente lo contrario; en cualquier caso, no incurrirá en ningún cargo como resultado de dicho reembolso.
Podremos retener el reembolso hasta que hayamos recibido los bienes o hasta que nos haya presentado una prueba de que los ha devuelto, lo que ocurra primero.
Deberá devolver los bienes o entregarlos a moluna, Greven, Germany, sin demoras indebidas y, en cualquier caso, en un plazo máximo de 14 días a partir del día en que nos comunique su desistimiento del presente contrato. El plazo se cumple si devuelve la mercancía antes de que venza el periodo de 14 días. Tendrá que asumir los gastos directos de devolución de los bienes. Usted solo es responsable de la disminución del valor de los bienes como resultado de una manipulación distinta a la necesaria para establecer la naturaleza, las características y el funcionamiento de los bienes.
Excepciones al derecho de desistimiento
El derecho de desistimiento no se aplica a lo siguiente:
- La entrega de periódicos, diarios o revistas, con la excepción de los contratos de suscripción; y
- El suministro de contenido digital que no se proporcione en un soporte tangible (por ejemplo, en un CD o DVD) si, al hacer el pedido, aceptó que podíamos empezar a entregarlo y que no podría desistir una vez iniciada la entrega.